Atlanta, GA — July 28, 2026 — Andson Biotech is excited to announce its participation in the International Mass Spectrometry Conference (IMSC 2026), taking place August 22–28, 2026, in Lyon, France. The company will exhibit at Booth 38 and present new scientific advances demonstrating how automated sample preparation workflows are helping researchers unlock the full potential of Native Mass Spectrometry (Native MS), Charge Detection Mass Spectrometry (CDMS), and biopharmaceutical analysis.
As mass spectrometry continues to play an increasingly important role in drug discovery and biotherapeutic development, researchers are seeking solutions that reduce sample preparation complexity while maintaining the integrity of challenging biomolecular samples. Andson Biotech has been innovating to develop automated online buffer exchange technology to enable faster, more reproducible, and higher-throughput workflows across a range of advanced analytical applications.
Scientific Presentations
At IMSC 2026, Andson Biotech will present how automated online buffer exchange and sample preparation workflows are helping expand the adoption of Native Mass Spectrometry and Charge Detection Mass Spectrometry by reducing workflow complexity and increasing throughput.
Presentations will highlight applications including:
- Protein–ligand screening and non-covalent complex characterization
- Biotherapeutic characterization and protein complex analysis
- Viral vector (AAV), RNA, and other advanced therapeutic modalities
- High-mass native complexes and heterogeneous biomolecules
- Direct analysis from cell culture media
- Accelerated process development and real-time bioprocess insights
Attendees will learn how automated sample preparation, online buffer exchange, and nanoflow infusion technologies can help streamline sample handling, preserve native interactions, and generate high-quality, reproducible data across a wide range of research and biopharmaceutical applications.
Join Andson Biotech in Lyon (Booth 38) to discover how streamlined sample preparation can accelerate scientific insight and expand the reach of Native Mass Spectrometry.
About Andson Biotech
Andson Biotech develops innovative microfluidic technologies that simplify sample preparation and enable advanced analytical workflows, helping researchers and pharmaceutical companies accelerate discovery and advance next-generation biotherapeutics.
